drug

Bromocriptin

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University Hospital, Bonn
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
NCT00315081Phase 3Unknown

KOLs & investigators

1
Wolfgang Maier, Prof. Dr.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University Hospital, Bonn
company
trial
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
PHASE3
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Hyperprolactinemia
indication
Hyperprolactinemia
indication
KOL
Wolfgang Maier, Prof. Dr.
KOL score —
person